TipRanks
pc:adc0v

Adcendo ApS

Nordre Fasanvej 215 Frederiksberg, Capital Region of Denmark 2000, DK
https://adcendo.com/
Adcendo ApS is a biotechnology company developing first- and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical need. The company is advancing a clinical ADC pipeline including programs ADCE-T02 (Tissue Factor), ADCE-D01 (uPARAP), and ADCE-B05, focusing on dose escalation and expansion studies across multiple tumor indications.

Leadership & Board

Current Number of Employees67
Current LinkedIn Followers11,204

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$75M
Total Amount Raised$75M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$75M
Latest Funding Amount$75M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Employee Trend

Adcendo ApS had 67 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
67Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Adcendo ApS had 11,204 followers as of September 14, 2026. The number of followers increased by 35 (0.31%) week-over-week.
11,204Latest Followers Count
35(0.31%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 14, 2026
Series C
$75.00M

Investors

Investor Name
Funding Round
Series C
Series C

Similar Companies

A snapshot of private companies similar to Adcendo ApS, helping you discover and navigate related company profiles.

Related News and Analysis